[接种17D-EP株疫苗者的病毒血症与黄热病疫苗血清抗体之间的关系] - Suppr | 超能文献

[Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP].

作者信息

Santiago Actis A, Sa Fleitas M J

出版信息

Rev Sanid Milit Argent. 1970 Jan-Jun;69(1):51-63.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP].[接种17D-EP株疫苗者的病毒血症与黄热病疫苗血清抗体之间的关系]

Rev Sanid Milit Argent. 1970 Jan-Jun;69(1):51-63.

2

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.接种黄热病病毒17D株后病毒血症的发展以及免疫激活的体液和细胞参数：一种人类黄病毒感染模型

J Med Virol. 1998 Oct;56(2):159-67. doi: 10.1002/(sici)1096-9071(199810)56:2<159::aid-jmv10>3.0.co;2-b.

3

Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.17DD和世界卫生组织17D-213/77黄热病疫苗在儿童中的免疫原性和反应原性的随机、双盲、多中心研究：对巴西国家免疫规划的影响

Vaccine. 2007 Apr 20;25(16):3118-23. doi: 10.1016/j.vaccine.2007.01.053. Epub 2007 Jan 22.

4

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?黄热病疫苗——它是如何起作用的，以及为什么会发生罕见的严重不良事件？

Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10.

5

Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.伊佩图-伊热萨的黄热病疫情：大规模疫苗接种后的应对措施

Rev Roum Virol. 1993 Jan-Jun;44(1-2):3-7.

6

Lymphocytes and yellow fever. I. Transient virus refractory state following vaccination of man with the 17-D strain.淋巴细胞与黄热病。I. 人体接种17-D株疫苗后的短暂病毒不应期

J Immunol. 1970 Nov;105(5):1304-6.

7

[Yellow fever].[黄热病]

Przegl Epidemiol. 2004;58 Suppl 1:101-5.

8

Yellow fever-associated viscerotropic disease in Barcelona, Spain.西班牙巴塞罗那的黄热病相关内脏型疾病

J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x.

9

Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.在秘鲁健康婴幼儿中开展的关于两种黄热病17D疫苗（Arilvax和YF-VAX）的免疫原性、安全性和耐受性比较的随机、双盲、III期关键现场试验。

Am J Trop Med Hyg. 2005 Feb;72(2):189-97.

10

Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.黄热病病毒17D包膜蛋白和NS3蛋白是小鼠抗病毒T细胞反应的主要靶点。

Virology. 2002 Apr 25;296(1):117-24. doi: 10.1006/viro.2002.1432.

引用本文的文献

1

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.17DD 黄热病疫苗：免疫原性和安全性的双盲、随机临床试验，剂量反应研究。

Hum Vaccin Immunother. 2013 Apr;9(4):879-88. doi: 10.4161/hv.22982. Epub 2013 Jan 30.